News

The new data reveals that Advitech’s fraction is capable of enhancing biochemical activity of fibroblasts (relative to cell proliferation and collagen synthesis) while preventing physiological phenomena that can

The trial will enroll a total of 220 patients at approximately 45 sites in approximately 20 states and will assess efficacy, safety and patient quality of life as

Amrix had similar efficacy to cyclobenzaprine immediate-release (CIR) taken three times a day in alleviating acute muscle spasm associated with lower back and neck pain. In addition, less

David Scopes, chief scientific officer of Senexis, said: “We believe our collaboration with O2H leverages the complementary expertise of both organisations and will benefit our search for new

The company and a selling stockholder have granted the underwriters a 30-day option to purchase up to an additional 698,333 shares and 66,667 shares, respectively, at the initial

The agreement mainly focuses on expanding research on the technology to be used for the delivery of proton therapy and developing new protocols using protons to treat a

The first patent claims a layered immediate-release (IR) tablet having at least two different active ingredients segregated from each other by a drug-free layer. The innovative tablet design

The primary endpoint of the study is to evaluate the safety and effectiveness of lixivaptan, when compared to placebo, in increasing serum sodium from baseline in heart failure

The European Medicines Agency (EMEA) orphan drug designation program is dedicated to stimulate and support the development of pharmaceuticals to treat life-threatening or very serious and rare diseases,